The independent source for health policy research, polling, and news.
6,721 - 6,740 of 15,443 Results
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Margot Sanger-Katz of The New York Times, Anna Edney of Bloomberg News and Julie Appleby of Kaiser Health News discuss the health politics of the latest Supreme Court pick, as well as the Trump administration’s efforts to further undermine the Affordable Care Act. Plus, for extra credit, the panelists recommend their favorite health stories of the week.
Medicaid has struggled for years with poor oversight and billions lost to improper payments. A new report finds that despite their fraud-fighting rhetoric, Medicaid managed-care companies are not as rigorous as they should be in ensuring the integrity of the Medicaid payment system.
Patients and caregivers often feel abandoned and lose trust in health care professionals when they sense a lack of caring during transitions. With it, they feel better able to handle concerns and act on their doctors’ recommendations.
Advocates of the sweeping health law view this move by the Trump administration as its most recent act of sabotage. But not everyone views it as a mortal blow.
The Trump administration suspended a program over the weekend that helps stabilize the health insurance exchanges created by the Affordable Care Act, prompting some insurance companies to warn of higher premiums. KHN's Julie Rovner and Chad Terhune explain the uncertain health care landscape in the U.S.
As the number of people with Alzheimer's climbs, so does the number of loved ones caring for them. The health of 16 million unpaid U.S. caregivers has become a focus for Alzheimer's advocacy groups.
Senate Democrats see health care as an issue that could keep their caucus unified as the confirmation battle heats up.
As with current abortion policies, a woman’s access to the procedure would continue to be determined by where she lives.
As Americans get older, it helps to tickle the ol' noggin with trivia. Take this pop quiz to see what you have learned as a regular reader of KHN’s coverage of aging issues.
Other readers ask what can be done to challenge unexpected medical bills — whether the result of an emergency room visit or after a change in prescription drug coverage.
A survey of 49 states reveals that an estimated 144,000 inmates with hepatitis C, a curable but potentially fatal disease, can’t get the expensive drugs they need to cure it.
Seniors who outlive their friends — and sometimes family members — know it’s tough to make new friends. But they also know it’s essential to well-being.
KHN’s newsletter editor, Brianna Labuskes, wades through hundreds of health articles from the week so you don’t have to.
The nation’s effort to combat this public health crisis could get caught in the crossfire of the Trump administration’s trade policies.
Some firefighters, emergency medical providers and law enforcement officers say recent mass shootings and other calamities — disturbing enough in themselves — have brought to the surface trauma buried over years on the job. Many are reluctant to seek help, though some employers are trying to change that.
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Joanne Kenen of Politico, Stephanie Armour of The Wall Street Journal and Anna Edney of Bloomberg News discuss the latest enrollment numbers for the Affordable Care Act, Medicaid work requirements in Kentucky and President Donald Trump’s proposed government reorganization plan. Plus, for extra credit, the panelists recommend their favorite health stories of the week.
Efforts to provide care that integrates physical and mental health services are spreading, partly because untreated mental health conditions negatively affect physical health and escalate health care costs.
The CEO of Comprehensive Pain Specialists was indicted in April. Now the group is closing clinics across several states.
Two Missouri hospitals handed over their operations to a private company that has vastly increased the money the hospitals bring in through their laboratories, even though the lab tests are not done on-site.
It’s getting increasingly difficult for patients to afford Truvada, also known as pre-exposure prophylaxis, or PrEP, because of the drug’s high price and insurance company efforts to restrict the use of coupons that shield patients from it.
© 2026 KFF